3.50
price up icon0.57%   0.02
 
loading
Polypid Ltd stock is traded at $3.50, with a volume of 54,985. It is up +0.57% in the last 24 hours and down -6.91% over the past month. PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
See More
Previous Close:
$3.48
Open:
$3.46
24h Volume:
54,985
Relative Volume:
0.11
Market Cap:
$55.64M
Revenue:
-
Net Income/Loss:
$-23.87M
P/E Ratio:
-0.1779
EPS:
-19.67
Net Cash Flow:
$-47.63M
1W Performance:
+1.45%
1M Performance:
-6.91%
6M Performance:
+17.06%
1Y Performance:
+1.16%
1-Day Range:
Value
$3.4405
$3.5599
1-Week Range:
Value
$3.42
$3.57
52-Week Range:
Value
$2.30
$3.93

Polypid Ltd Stock (PYPD) Company Profile

Name
Name
Polypid Ltd
Name
Phone
-
Name
Address
-
Name
Employee
61
Name
Twitter
Name
Next Earnings Date
2024-11-13
Name
Latest SEC Filings
Name
PYPD's Discussions on Twitter

Compare PYPD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PYPD
Polypid Ltd
3.50 55.80M 0 -23.87M -47.63M -19.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Polypid Ltd Stock (PYPD) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-05-25 Initiated Roth Capital Buy
Jun-02-25 Resumed H.C. Wainwright Buy
Jan-28-25 Initiated Rodman & Renshaw Buy
Sep-14-21 Initiated JMP Securities Mkt Outperform
Jul-30-21 Initiated Cantor Fitzgerald Overweight
Nov-24-20 Upgrade Raymond James Outperform → Strong Buy
Aug-10-20 Initiated Alliance Global Partners Buy
Jul-21-20 Initiated BMO Capital Markets Outperform
Jul-21-20 Initiated Barclays Overweight
Jul-21-20 Initiated Raymond James Outperform
View All

Polypid Ltd Stock (PYPD) Latest News

pulisher
Aug 20, 2025

Will PolyPid Ltd. Sustain Its Chart Breakout2025 Stock Rankings & High Conviction Buy Zone Alerts - thegnnews.com

Aug 20, 2025
pulisher
Aug 20, 2025

PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Will PolyPid Ltd. Reverse From Oversold ConditionsQuarterly Performance Summary & Weekly Setup with High ROI Potential - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Risk adjusted return profile for PolyPid Ltd. analyzedStock Surge & Stock Portfolio Risk Control - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Pattern recognition hints at PolyPid Ltd. upsideJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Does PolyPid Ltd. qualify in momentum factor screeningInflation Watch & Low Risk High Win Rate Stock Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What high frequency data says about PolyPid Ltd.Weekly Risk Summary & Reliable Intraday Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Does PolyPid Ltd. fit your quant trading modelEarnings Performance Report & Fast Entry Momentum Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Short interest data insights for PolyPid Ltd.Earnings Overview Summary & Advanced Technical Signal Analysis - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Will PolyPid Ltd. benefit from macro trendsWeekly Profit Recap & AI Optimized Trade Strategies - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can technical indicators confirm PolyPid Ltd.’s reversalGDP Growth & Safe Capital Growth Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What’s the recovery path for long term holders of PolyPid Ltd.2025 Price Targets & Precise Trade Entry Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Forecasting PolyPid Ltd. price range with options dataJuly 2025 Earnings & Daily Market Momentum Tracking - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Live market analysis of PolyPid Ltd.Gap Down & Free Real-Time Volume Trigger Notifications - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will breakout in PolyPid Ltd. lead to full recoveryAnalyst Downgrade & Risk Controlled Daily Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Machine Learning Models Forecast PolyPid Ltd. UptickWeekly Market Report & Risk Controlled Stock Pick Alerts - newsyoung.net

Aug 19, 2025
pulisher
Aug 19, 2025

How institutional ownership impacts PolyPid Ltd. stockVolume Spike & Daily Momentum Trading Reports - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Roth Capital Has Negative Outlook for PolyPid Q3 Earnings - Defense World

Aug 18, 2025
pulisher
Aug 17, 2025

Detecting price anomalies in PolyPid Ltd. with AIGap Down & Comprehensive Market Scan Insights - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Sector ETF performance correlation with PolyPid Ltd.July 2025 Short Interest & Fast Moving Stock Watchlists - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Can PolyPid Ltd. lead its sector in growthWeekly Earnings Recap & Target Return Focused Picks - classian.co.kr

Aug 17, 2025
pulisher
Aug 17, 2025

Is PolyPid Ltd. forming a breakout patternQuarterly Profit Summary & Daily Stock Momentum Reports - classian.co.kr

Aug 17, 2025
pulisher
Aug 17, 2025

Custom watchlist performance reports with PolyPid Ltd.2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Developing predictive dashboards with PolyPid Ltd. dataMarket Sentiment Review & Long-Term Safe Return Strategies - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

PolyPid Ltd. stock volume spike explainedWeekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

PolyPid (NASDAQ:PYPD) Rating Lowered to “Sell” at Wall Street Zen - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

HC Wainwright Has Negative Outlook for PolyPid Q3 Earnings - Defense World

Aug 16, 2025
pulisher
Aug 16, 2025

PolyPid Ltd. Company Revenue and Profit Trends: A Deep DiveAnalyst Upgrade & Safe Entry Zone Tips - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Why PolyPid Ltd. stock attracts strong analyst attentionSell Signal & Safe Entry Trade Reports - Newser

Aug 15, 2025

Polypid Ltd Stock (PYPD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):